| Mangalam Drugs and Organics Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 532637 |
NSE Symbol : MANGALAM |
P/E(TTM) : 0.00 |
|
ISIN Demat : INE584F01014 |
Div & Yield% : 0.00 |
EPS(TTM) : 0.00 |
|
Book Value(₹) : 80.50 |
Market Cap(₹Cr) : 40.11 |
Face Value(₹) : 10.00 |
| Particulars | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|
| Gross Sales | 49.26 | 57.21 | 72.78 | 88.55 | 79.75 | 76.49 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 49.26 | 57.21 | 72.78 | 88.55 | 79.75 | 76.49 |
| Other Operating Income | 0.28 | 0.14 | 0.26 | 0.16 | 0.19 | 0.04 |
| Other Income | 0.03 | 0.00 | 0.21 | 0.13 | 0.14 | 0.02 |
| Total Income | 49.57 | 57.35 | 73.25 | 88.84 | 80.08 | 76.56 |
| Total Expenditure | 52.38 | 61.85 | 62.88 | 79.94 | 71.25 | 68.35 |
| PBIDT | -2.81 | -4.50 | 10.37 | 8.90 | 8.83 | 8.21 |
| Interest | 5.03 | 4.04 | 4.03 | 3.49 | 3.67 | 3.75 |
| PBDT | -7.83 | -8.55 | 6.34 | 5.41 | 5.16 | 4.46 |
| Depreciation | 4.53 | 4.38 | 4.61 | 3.93 | 3.97 | 3.87 |
| Tax | 0.00 | 0.00 | 0.07 | 0.00 | 0.01 | 0.00 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | -5.12 | 0.80 | 1.50 | 0.08 | -1.50 | -2.10 |
| Reported Profit After Tax | -7.25 | -13.73 | 0.15 | 1.40 | 2.69 | 2.68 |
| Extra-ordinary Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Adjusted Profit After Extra-ordinary item | -7.25 | -13.73 | 0.15 | 1.40 | 2.69 | 2.68 |
| EPS (Unit Curr.) | -4.58 | -8.67 | 0.10 | 0.89 | 1.70 | 1.70 |
| EPS (Adj) (Unit Curr.) | -4.58 | -8.67 | 0.10 | 0.89 | 1.70 | 1.70 |
| Calculated EPS (Unit Curr.) | -4.58 | -8.67 | 0.10 | 0.89 | 1.70 | 1.70 |
| Calculated EPS (Adj) (Unit Curr.) | -4.58 | -8.67 | 0.10 | 0.89 | 1.70 | 1.70 |
| Calculated EPS (Ann.) (Unit Curr.) | -18.31 | -34.69 | 0.38 | 3.54 | 6.79 | 6.78 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | -18.31 | -34.69 | 0.38 | 3.54 | 6.79 | 6.78 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity | 15.83 | 15.83 | 15.83 | 15.83 | 15.83 | 15.83 |
| Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Face Value | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | -5.70 | -7.87 | 14.25 | 10.05 | 11.07 | 10.73 |
| PBDTM(%) | -15.90 | -14.94 | 8.71 | 6.11 | 6.47 | 5.83 |
| PATM(%) | -14.72 | -24.00 | 0.21 | 1.58 | 3.37 | 3.50 |